US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 26.370
  • -0.690-2.55%
Close Aug 28 16:00 ET
1.88BMarket Cap-175800P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
-32.37%67.05M
164.99%71.47M
50.19%48.35M
471.24%220.18M
230.14%61.88M
719.64%99.14M
Operating revenue
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
-32.37%67.05M
164.99%71.47M
50.19%48.35M
471.24%220.18M
230.14%61.88M
719.64%99.14M
Cost of revenue
95.23%42.34M
104.80%31.38M
45.91%33.41M
-204.92%-30M
128.37%26.4M
149.22%21.69M
22.86%15.32M
151.59%22.9M
-354.43%-9.84M
317.78%11.56M
Gross profit
33.15%66.3M
46.80%48.47M
20.06%236.85M
58.10%113.4M
-53.59%40.65M
172.50%49.79M
67.48%33.02M
570.03%197.29M
382.07%71.72M
838.84%87.58M
Operating expense
25.44%66.41M
47.04%65.02M
39.75%262.05M
72.54%113.32M
25.30%51.57M
40.66%52.94M
2.75%44.22M
0.77%187.51M
28.75%65.68M
2.92%41.16M
Selling and administrative expenses
45.31%42.4M
33.18%38.68M
32.13%129.43M
35.00%36.74M
39.68%34.47M
22.37%29.18M
30.73%29.05M
13.97%97.95M
19.67%27.22M
18.87%24.68M
Research and development costs
1.05%24.02M
73.57%26.33M
16.20%76.1M
39.35%20.05M
3.77%17.11M
72.25%23.77M
-27.12%15.17M
-34.05%65.49M
-47.54%14.39M
-14.30%16.49M
Other operating expenses
----
----
134.82%56.52M
----
----
----
----
2,782.75%24.07M
----
----
Operating profit
96.29%-117K
-47.75%-16.54M
-357.81%-25.2M
-98.66%81K
-123.54%-10.93M
83.72%-3.15M
51.99%-11.2M
106.24%9.77M
116.74%6.05M
251.35%46.41M
Net non-operating interest income expense
Other net income (expense)
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
654.04%2.43M
1,759.22%1.92M
5,288.24%1.83M
1,191.75%1.25M
794K
322K
Other non- operating income (expenses)
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
654.04%2.43M
1,759.22%1.92M
5,288.24%1.83M
1,191.75%1.25M
--794K
--322K
Income before tax
285.96%2.3M
-52.46%-14.28M
-251.02%-16.65M
-64.19%2.45M
-118.19%-8.5M
93.57%-1.24M
59.79%-9.36M
107.04%11.03M
118.97%6.84M
252.42%46.74M
Income tax
138.32%6.21M
17.96%3.43M
82.17%-30.74M
-1,057.44%-22.79M
103.02%5.36M
-2,364.11%-16.21M
50.96%2.91M
-12,543.10%-172.34M
753.05%2.38M
-150,203.39%-177.36M
Net income
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
833.67%224.09M
Net income continuous Operations
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
833.67%224.09M
Minority interest income
Net income attributable to the parent company
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
833.67%224.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
833.67%224.09M
Basic earnings per share
-128.57%-0.06
-38.89%-0.25
-92.42%0.2
500.00%0.36
-106.19%-0.2
172.41%0.21
50.00%-0.18
214.78%2.64
111.32%0.06
834.09%3.23
Diluted earnings per share
-128.57%-0.06
-38.89%-0.25
-92.31%0.2
483.33%0.35
-106.29%-0.2
172.41%0.21
50.00%-0.18
213.04%2.6
111.32%0.06
822.73%3.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M-32.37%67.05M164.99%71.47M50.19%48.35M471.24%220.18M230.14%61.88M719.64%99.14M
Operating revenue 51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M-32.37%67.05M164.99%71.47M50.19%48.35M471.24%220.18M230.14%61.88M719.64%99.14M
Cost of revenue 95.23%42.34M104.80%31.38M45.91%33.41M-204.92%-30M128.37%26.4M149.22%21.69M22.86%15.32M151.59%22.9M-354.43%-9.84M317.78%11.56M
Gross profit 33.15%66.3M46.80%48.47M20.06%236.85M58.10%113.4M-53.59%40.65M172.50%49.79M67.48%33.02M570.03%197.29M382.07%71.72M838.84%87.58M
Operating expense 25.44%66.41M47.04%65.02M39.75%262.05M72.54%113.32M25.30%51.57M40.66%52.94M2.75%44.22M0.77%187.51M28.75%65.68M2.92%41.16M
Selling and administrative expenses 45.31%42.4M33.18%38.68M32.13%129.43M35.00%36.74M39.68%34.47M22.37%29.18M30.73%29.05M13.97%97.95M19.67%27.22M18.87%24.68M
Research and development costs 1.05%24.02M73.57%26.33M16.20%76.1M39.35%20.05M3.77%17.11M72.25%23.77M-27.12%15.17M-34.05%65.49M-47.54%14.39M-14.30%16.49M
Other operating expenses --------134.82%56.52M----------------2,782.75%24.07M--------
Operating profit 96.29%-117K-47.75%-16.54M-357.81%-25.2M-98.66%81K-123.54%-10.93M83.72%-3.15M51.99%-11.2M106.24%9.77M116.74%6.05M251.35%46.41M
Net non-operating interest income expense
Other net income (expense) 26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M654.04%2.43M1,759.22%1.92M5,288.24%1.83M1,191.75%1.25M794K322K
Other non- operating income (expenses) 26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M654.04%2.43M1,759.22%1.92M5,288.24%1.83M1,191.75%1.25M--794K--322K
Income before tax 285.96%2.3M-52.46%-14.28M-251.02%-16.65M-64.19%2.45M-118.19%-8.5M93.57%-1.24M59.79%-9.36M107.04%11.03M118.97%6.84M252.42%46.74M
Income tax 138.32%6.21M17.96%3.43M82.17%-30.74M-1,057.44%-22.79M103.02%5.36M-2,364.11%-16.21M50.96%2.91M-12,543.10%-172.34M753.05%2.38M-150,203.39%-177.36M
Net income -126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M833.67%224.09M
Net income continuous Operations -126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M833.67%224.09M
Minority interest income
Net income attributable to the parent company -126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M833.67%224.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M833.67%224.09M
Basic earnings per share -128.57%-0.06-38.89%-0.25-92.42%0.2500.00%0.36-106.19%-0.2172.41%0.2150.00%-0.18214.78%2.64111.32%0.06834.09%3.23
Diluted earnings per share -128.57%-0.06-38.89%-0.25-92.31%0.2483.33%0.35-106.29%-0.2172.41%0.2150.00%-0.18213.04%2.6111.32%0.06822.73%3.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg